Back
Candel Therapeutics Vs. NovaBay Pharmaceuticals Industry Stock Comparison
Buy
59
CADL
Candel Therapeutics
Last Price:
$8.74
Seasonality Move:
-11.47%
Sell
19
NBY
NovaBay Pharmaceuticals
Last Price:
$0.53
Seasonality Move:
-0.66%
Buy
59
Candel Therapeutics (CADL)
is a Buy
Is Candel Therapeutics a Buy, Sell or Hold?
-
The current Candel Therapeutics [CADL] share price is $8.75. The Score for CADL is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
-
CADL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
19
NovaBay Pharmaceuticals (NBY)
is a Sell
Is NovaBay Pharmaceuticals a Buy, Sell or Hold?
-
The current NovaBay Pharmaceuticals [NBY] share price is $0.53. The Score for NBY is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
-
NBY is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
CADL Stock Price Chart
What is Candel Therapeutics's stock price today?
-
The Candel Therapeutics share price today is $8.75Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CADL is experiencing slight selling pressure.
NBY Stock Price Chart
What is NovaBay Pharmaceuticals's stock price today?
-
The NovaBay Pharmaceuticals share price today is $0.53The current trend is relatively stagnant and NBY is experiencing buying pressure, which is a positive indicator for future bullish movement.
CADL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.87 | Buy |
Relative Strength Index (14 RSI): | 61.32 | Buy |
Chaikin Money Flow: | -2064192 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (3.83 - 7.33) | Buy |
Bollinger Bands (100): | (4.74 - 6.98) | Buy |
NBY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.04 | Sell |
Relative Strength Index (14 RSI): | 39.44 | Sell |
Chaikin Money Flow: | 514099 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.53 - 0.67) | Sell |
Bollinger Bands (100): | (0.49 - 0.69) | Sell |
CADL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 7.79 | Buy |
20-day SMA: | 5.98 | Buy |
50-day SMA: | 5.49 | Buy |
200-day SMA: | 6.1 | Buy |
8-day EMA: | 7.58 | Buy |
20-day EMA: | 6.46 | Buy |
50-day EMA: | 5.89 | Buy |
200-day EMA: | 5.41 | Buy |
NBY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.54 | Sell |
20-day SMA: | 0.57 | Sell |
50-day SMA: | 0.63 | Sell |
200-day SMA: | 1.88 | Sell |
8-day EMA: | 0.54 | Sell |
20-day EMA: | 0.57 | Sell |
50-day EMA: | 0.64 | Sell |
200-day EMA: | 4.7 | Sell |
Candel Therapeutics Earnings Growth & CADL Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.14 per share, and an increase next year of $0.03 per share.
NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $77.59 per share, and an increase next year of $2.44 per share.
Candel Therapeutics Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
NovaBay Pharmaceuticals Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |